cdifffoundation.org
DEINOVE Announced Enrollment of First Patient in Phase II Trial Testing DNV3837 in Clostridioides difficile infections
On January 27, 2020, DEINOVE announced the inclusion of the first patient in the Phase II trial testing DNV3837. The Phase II clinical trial aims to evaluate the efficacy, safety, and pharma…